| 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained M Zanoni, F Piccinini, C Arienti, A Zamagni, S Santi, R Polico, ... Scientific reports 6 (1), 19103, 2016 | 1180 | 2016 |
| Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches M Consortium, WKW Théry C J Extracell Vesicles, 2024 | 1036 | 2024 |
| Modeling neoplastic disease with spheroids and organoids M Zanoni, M Cortesi, A Zamagni, C Arienti, S Pignatta, A Tesei Journal of Hematology & Oncology 13 (1), 1-15, 2020 | 226 | 2020 |
| Anticancer drug discovery using multicellular tumor spheroid models M Zanoni, S Pignatta, C Arienti, M Bonafè, A Tesei Expert opinion on drug discovery 14 (3), 289-301, 2019 | 105 | 2019 |
| The role of mesenchymal stem cells in radiation-induced lung fibrosis M Zanoni, M Cortesi, A Zamagni, A Tesei International journal of molecular sciences 20 (16), 3876, 2019 | 99 | 2019 |
| Glutathione, glutathione disulfide, and S-glutathionylated proteins in cell cultures D Giustarini, F Galvagni, A Tesei, A Farolfi, M Zanoni, S Pignatta, ... Free Radical Biology and Medicine 89, 972-981, 2015 | 96 | 2015 |
| Sigma receptors as endoplasmic reticulum stress “gatekeepers” and their modulators as emerging new weapons in the fight against cancer A Tesei, M Cortesi, A Zamagni, C Arienti, S Pignatta, M Zanoni, M Paolillo, ... Frontiers in pharmacology 9, 711, 2018 | 74 | 2018 |
| MISpheroID: a knowledgebase and transparency tool for minimum information in spheroid identity A Peirsman, E Blondeel, T Ahmed, J Anckaert, D Audenaert, T Boterberg, ... Nature methods 18 (11), 1294-1303, 2021 | 64 | 2021 |
| Emerging roles of aldehyde dehydrogenase isoforms in anti-cancer therapy resistance M Zanoni, S Bravaccini, F Fabbri, C Arienti Frontiers in Medicine 9, 795762, 2022 | 60 | 2022 |
| The androgen receptor/filamin A complex as a target in prostate cancer microenvironment M Di Donato, A Zamagni, G Galasso, E Di Zazzo, P Giovannelli, ... Cell Death & Disease 12 (1), 127, 2021 | 60 | 2021 |
| The androgen receptor/filamin A complex as a target in prostate cancer microenvironment M Di Donato, A Zamagni, G Galasso, E Di Zazzo, P Giovannelli, ... Cell Death & Disease 12 (1), 127, 2021 | 60 | 2021 |
| Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer C Arienti, M Zanoni, S Pignatta, A Del Rio, S Carloni, M Tebaldi, G Tedaldi, ... Oncotarget 7 (14), 18424, 2016 | 59 | 2016 |
| P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells A Pegoraro, E De Marchi, M Ferracin, E Orioli, M Zanoni, C Bassi, A Tesei, ... Cell death & disease 12 (12), 1088, 2021 | 54 | 2021 |
| Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians G Storci, S De Carolis, A Papi, MG Bacalini, N Gensous, E Marasco, ... Cell Death & Differentiation 26 (9), 1845-1858, 2019 | 52 | 2019 |
| Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight M Cortesi, M Zanoni, F Pirini, MM Tumedei, S Ravaioli, IG Rapposelli, ... International journal of molecular sciences 23 (1), 254, 2021 | 51 | 2021 |
| Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients? R Maltoni, S Ravaioli, G Bronte, M Mazza, C Cerchione, I Massa, W Balzi, ... Translational Oncology 15 (1), 101300, 2022 | 45 | 2022 |
| Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma M Zanoni, AC Sarti, A Zamagni, M Cortesi, S Pignatta, C Arienti, M Tebaldi, ... Cell Death & Disease 13 (1), 80, 2022 | 37 | 2022 |
| TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer A Tesei, C Arienti, G Bossi, S Santi, I De Santis, A Bevilacqua, M Zanoni, ... Journal of Experimental & Clinical Cancer Research 40 (1), 1-15, 2021 | 36 | 2021 |
| CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems C Liverani, L Mercatali, C Spadazzi, F La Manna, A De Vita, N Riva, ... Bone 66, 214-222, 2014 | 36 | 2014 |
| Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines Corrigendum in/10.3892/ijo. 2016.3613 T Ibrahim, C Liverani, L Mercatali, E Sacanna, M Zanoni, F Fabbri, W Zoli, ... International journal of oncology 42 (4), 1263-1270, 2013 | 36 | 2013 |
